Funding medical research is about more than just numbers. It's real people,” says Ryan Manriquez, president of the UC ...

Biogen is planning to trial its Spinraza spinal muscular atrophy (SMA) drug in patients who have not responded properly to Novartis' gene therapy Zolgensma, combining the two ultra-expensive ...

Sales of Biogen’s BIIB key multiple sclerosis (“MS”) drugs like Tecfidera and Tysabri and spinal muscular atrophy (SMA) treatment, Spinraza, are being hurt due to competitive pressure ...

Due to the drug Spinraza, Emma, who was there Monday with her parents, Dianne and Matt, she was able to crawl again and occasionally use a walker. The Great Hollow sixth grader now has a 4.4 GPA ...

Spinraza continued to decline in 2021 ... patients as well as to be administered at extended dosing intervals." The drug stems from an alliance between Ionis and Biogen that dates back almost ...